Related Articles
Periostin expression in cancer-associated fibroblasts of invasive ductal breast carcinoma
Estrogen receptor α and β, progesterone receptor, pS2 and HER-2/neu expression delineate different subgroups in ductal carcinoma in situ of the breast
HPK1 positive expression associated with longer overall survival in patients with estrogen receptor-positive invasive ductal carcinoma‑not otherwise specified
Interaction between cyclooxygenase-2 and insulin-like growth factor in breast cancer: A new field for prevention and treatment
Correlation of p53 and cerbB2 expression and hormonal receptor status with clinicopathologic parameters in ductal carcinoma in situ of the breast